OneMedNet Corp Chief Medical Officer Yu Jeffrey bought 142,857 shares at $0.63 per share on September 10, 2026. The purchase represented about 1.6% of his resulting 8,923,267-share holding, giving investors the disclosed transaction size, price and resulting ownership position in one view.
Key Highlights
- Yu Jeffrey’s post-transaction holding stood at 8,923,267 OneMedNet Corp shares.
- The purchase represented about 1.6% of Yu Jeffrey’s resulting shareholding.
- Yu Jeffrey bought 142,857 OneMedNet Corp shares at $0.63 per share on September 10, 2026.
OneMedNet Corp (NASDAQ: ONMD) Chief Medical Officer Yu Jeffrey bought 142,857 shares at $0.63 per share. The purchase occurred on September 10, 2026.
Transaction Code P Reported in Filing
The filing reports transaction code P for the purchase. Yu Jeffrey’s resulting ownership position was 8,923,267 shares. Yu Jeffrey is identified in the filing as OneMedNet Corp’s chief medical officer. The purchase price was $0.63 per share. The acquired shares represented about 1.6% of Yu Jeffrey’s resulting shareholding. Transaction code P denotes an open-market or private purchase.
FAQs
Q: How many OneMedNet shares did Yu Jeffrey buy?
A: Yu Jeffrey bought 142,857 OneMedNet Corp shares at $0.63 per share on September 10, 2026. The filing identifies him as chief medical officer.
Q: What does the OneMedNet insider purchase mean for ONMD investors?
A: The filing records Yu Jeffrey’s purchase of 142,857 OneMedNet Corp shares under transaction code P. It reports that he owned 8,923,267 shares afterward.
Q: When did Yu Jeffrey buy OneMedNet shares?
A: Yu Jeffrey bought the OneMedNet Corp shares on September 10, 2026, according to the filing. The purchase represented about 1.6% of his resulting shareholding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.